316 related articles for article (PubMed ID: 16331103)
1. Assessment of the white-coat effect.
Gerin W; Ogedegbe G; Schwartz JE; Chaplin WF; Goyal T; Clemow L; Davidson KW; Burg M; Lipsky S; Kentor R; Jhalani J; Shimbo D; Pickering TG
J Hypertens; 2006 Jan; 24(1):67-74. PubMed ID: 16331103
[TBL] [Abstract][Full Text] [Related]
2. Determinants of the white-coat effect in normotensives and never-treated mild hypertensives.
Tsai PS
Clin Exp Hypertens; 2003 Oct; 25(7):443-54. PubMed ID: 14596368
[TBL] [Abstract][Full Text] [Related]
3. Assessing the white-coat effect: which blood pressure measurement should be considered?
Parati G; Mancia G
J Hypertens; 2006 Jan; 24(1):29-31. PubMed ID: 16331095
[No Abstract] [Full Text] [Related]
4. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators.
Parati G; Omboni S; Staessen J; Thijs L; Fagard R; Ulian L; Mancia G
J Hypertens; 1998 Jan; 16(1):23-9. PubMed ID: 9533413
[TBL] [Abstract][Full Text] [Related]
5. White coat effect detected using self-monitoring of blood pressure at home: comparison with ambulatory blood pressure.
Stergiou GS; Zourbaki AS; Skeva II; Mountokalakis TD
Am J Hypertens; 1998 Jul; 11(7):820-7. PubMed ID: 9683043
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.
Veglio F; Rabbia F; Riva P; Martini G; Genova GC; Milan A; Paglieri C; Carra R; Chiandussi L
Clin Exp Hypertens; 2001 Apr; 23(3):203-11. PubMed ID: 11339687
[TBL] [Abstract][Full Text] [Related]
7. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.
Staessen JA; Beilin L; Parati G; Waeber B; White W
Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536
[TBL] [Abstract][Full Text] [Related]
8. The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking.
Palatini P; Palomba D; Bertolo O; Minghetti R; Longo D; Sarlo M; Pessina AC
J Hypertens; 2003 Mar; 21(3):545-53. PubMed ID: 12640248
[TBL] [Abstract][Full Text] [Related]
9. Some implications of the differences between home, clinic and ambulatory blood pressure in normotensive and hypertensive patients.
Pickering TG; James GD
J Hypertens Suppl; 1989 May; 7(3):S65-72. PubMed ID: 2668466
[TBL] [Abstract][Full Text] [Related]
10. Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure.
Larkin KT; Schauss SL; Elnicki DM; Goodie JL
J Hum Hypertens; 2007 Jul; 21(7):516-24. PubMed ID: 17361194
[TBL] [Abstract][Full Text] [Related]
11. Nurse-measured or ambulatory blood pressure in routine hypertension care.
Veerman DP; van Montfrans GA
J Hypertens; 1993 Mar; 11(3):287-92. PubMed ID: 8387086
[TBL] [Abstract][Full Text] [Related]
12. Management of hypertension in the elderly using home blood pressures.
Broege PA; James GD; Pickering TG
Blood Press Monit; 2001 Jun; 6(3):139-44. PubMed ID: 11518836
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nurse- and physician-determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management.
La Batide-Alanore A; Chatellier G; Bobrie G; Fofol I; Plouin PF
J Hypertens; 2000 Apr; 18(4):391-8. PubMed ID: 10779088
[TBL] [Abstract][Full Text] [Related]
14. Difference between clinic and daytime blood pressure is not a measure of the white coat effect.
Parati G; Ulian L; Santucciu C; Omboni S; Mancia G
Hypertension; 1998 May; 31(5):1185-9. PubMed ID: 9576133
[TBL] [Abstract][Full Text] [Related]
15. White coat effect in treated versus untreated hypertensive individuals: a case-control study using ambulatory and home blood pressure monitoring.
Stergiou GS; Efstathiou SP; Argyraki CK; Roussias LG; Mountokalakis TD
Am J Hypertens; 2004 Feb; 17(2):124-8. PubMed ID: 14751653
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ
Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890
[TBL] [Abstract][Full Text] [Related]
17. White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients.
Høegholm A; Kristensen KS; Madsen NH; Svendsen TL
Am J Hypertens; 1992 Feb; 5(2):64-70. PubMed ID: 1550667
[TBL] [Abstract][Full Text] [Related]
18. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
19. The Norwegian office-, home-, and ambulatory blood pressure study (NOHA).
Omvik P; Gerhardsen G
Blood Press; 2003; 12(4):211-9. PubMed ID: 14596357
[TBL] [Abstract][Full Text] [Related]
20. Difference between office and ambulatory blood pressure and response to antihypertensive treatment.
Parati G; Omboni S; Mancia G
J Hypertens; 1996 Jun; 14(6):791-7. PubMed ID: 8793703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
